Nobel Award Recognizes Pioneering Immune System Discoveries

The Nobel Prize in Physiology or Medicine was granted for revolutionary discoveries that illuminate how the immune system attacks dangerous pathogens while sparing the healthy tissues.

A trio of esteemed researchers—from Japan Shimon Sakaguchi and US scientists Mary Brunkow and Fred Ramsdell—received this accolade.

Their research uncovered specialized "sentinels" within the immune system that remove rogue immune cells that could attacking the body.

The discoveries are now paving the way for new treatments for immune disorders and cancer.

The laureates will share a monetary award worth 11 million Swedish kronor.

Crucial Discoveries

"The work has been decisive for comprehending how the body's defenses operates and the reason we do not all develop severe autoimmune diseases," stated the chair of the Nobel Committee.

The team's studies address a core question: In what way does the immune system protect us from countless invaders while leaving our healthy cells intact?

Our body's protection system uses white blood cells that search for indicators of disease, including pathogens and germs it has not met before.

Such cells employ sensors—known as receptors—that are produced randomly in countless variations.

That gives the defense network the ability to fight a wide array of invaders, but the randomness of the mechanism unavoidably creates immune cells that can target the host.

Security Guards of the Body

Scientists earlier understood that a portion of these problematic defense cells were eliminated in the immune organ—where white blood cells develop.

This year's Nobel Prize recognizes the discovery of T-reg cells—known as the immune system's "peacekeepers"—which travel through the body to neutralize other immune cells that attack the body's own tissues.

We know that this mechanism fails in self-attack conditions such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The Nobel panel stated, "The discoveries have established a new field of investigation and spurred the creation of innovative treatments, for instance for tumors and autoimmune diseases."

In malignancies, regulatory T-cells block the body from attacking the tumor, so research are aimed at reducing their numbers.

In self-attack disorders, trials are testing boosting T-reg cells so the organism is no longer under attack. A comparable method could also be effective in minimizing the risks of transplanted organ rejection.

Pioneering Experiments

Prof Sakaguchi, from Osaka University, performed tests on rodents that had their thymus removed, causing self-attack conditions.

He showed that injecting immune cells from healthy mice could prevent the illness—implying there was a mechanism for blocking defenders from harming the body.

Dr. Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, now at a biotech firm in San Francisco, were studying an inherited autoimmune disease in rodents and people that led to the discovery of a gene vital for how regulatory T-cells function.

"The pioneering research has revealed how the body's defenses is controlled by T-reg cells, stopping it from mistakenly targeting the body's own tissues," said a leading biological science specialist.

"This research is a striking illustration of how basic biological research can have broad consequences for public health."